Persistence With Biological Disease-Modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs

Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-018-0139-8
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pnd96 - Four-Year Resource Use and Costs Associated With Administration and Monitoring of Disease Modifying Drugs in Patients With Multiple Sclerosis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2014English

Switching Biological Disease-Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis: Results From a Systematic Literature Review

RMD Open
RheumatologyAllergyImmunology
2017English

Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs

Reumatologia
RheumatologyAllergyImmunology
2014English

Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs

Arthritis Care and Research
Rheumatology
2020English

Biological Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis of Polyarticular Course, Enthesitis-Related Arthritis, and Psoriatic Arthritis: A Consensus Statement

2020English

Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis With Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLAR

Archives of Rheumatology
Rheumatology
2015English

Eligibility Criteria for Biologic Disease-Modifying Antirheumatic Drugs in Axial Spondyloarthritis: Going Beyond BASDAI

RMD Open
RheumatologyAllergyImmunology
2020English

FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy